Asmanex HFA

Generic name

Mometasone Furoate

Covered by Medicare


Get a Medicare Quote

Average Annual Cost per Beneficiary


Average cost per year*

Average Annual Cost per Dose



Average cost per beneficiary*


  • Organon LLC
  • Merck Sharp & D

What is Asmanex HFA

Mometasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Drug Trends

*Origin of the terms and chart data used within this page:

Common Questions About Asmanex HFA

Yes, Asmanex HFA is covered by Medicare.

In 2021, the average cost per dose of Asmanex HFA was $15.57.

The average dose of Asmanex HFA received per year is 587,061 units

10,808 Medicare beneficiaries received Asmanex HFA in 2021, which was a -0.14% from 2020

There were 30,735 claims made by Medicare beneficiaries, which is a -0.15% from 2020

The average spending amount per claim in 2021 was $274.31

The average Medicare spending per beneficiary amount for Asmanex HFA was $780.06

The most expensive manufacturer of Asmanex HFA is Merck Sharp & D

Organon LLC is the least expensive manufacturer with an Average Spending Per Dosage Unit of $15.56

Merck Sharp & D received $7,310,740.42

The total amount spent on Asmanex HFA by Medicare is $8,430,851.60

© 2021-2024, LLC

Privacy Policy  |  Terms and Conditions

GENERAL DISCLAIMERS is a commercial site designed for the solicitation of insurance from selected health insurance carriers and, LLC is a licensed insurance agency. It is not a government agency. It is also not an insurer, or a medical provider., LLC is a licensed representative of Medicare Advantage (HMO, PPO, PFFS, and PDP) organizations that have a Medicare contract. Enrollment depends on the plan’s contract renewal.
We do not offer every plan available in your area. Currently we represent nine carrier plan organizations nationally. Please contact, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.
Alternatively, you may be referred, via a link, to a selected partner website, which is independently owned and operated and may have different privacy and terms of use policies from us.
If you provide your contact information to us, an insurance agent/producer or insurance company may contact you. If you do not speak English, language assistance service, free of charge, is available to you; contact the toll-free number listed above. This site is not maintained by or affiliated with the federal government's Health Insurance Marketplace website or any state government health insurance marketplace.
The plans we represent do not discriminate on the basis of race, color, national origin, age, disability, or sex. To learn more about a plan's nondiscrimination policy, please click here.
Not all plans offer all of these benefits. Benefits may vary by carrier and location. Limitations and exclusions may apply.